Cabaletta Bio prices $150M stock offering
Source: SeekingAlpha
2026-05-04 07:03:43 ET
More on Cabaletta Bio
- Cellares’ Cell Shuttle used in first patient infusions of Cabaletta Bio CAR T therapy
- Cabaletta Bio GAAP EPS of -$0.40 beats by $0.06
- Seeking Alpha’s Quant Rating on Cabaletta Bio
- Historical earnings data for Cabaletta Bio
- Financial information for Cabaletta Bio
Read the full article on Seeking Alpha
For further details see:
Cabaletta Bio prices $150M stock offering
Eli Lilly and Company
NASDAQ: LLY
LLY Trading
1.0% G/L:
$1147.79 Last:
2,429,032 Volume:
$1143.38 Open:
LLY Latest News
June 06, 2026 03:35:00 pm
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing
June 06, 2026 02:30:00 pm
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
June 06, 2026 12:35:00 pm
Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems
LLY Stock Data
$977,526,804,738
935,929,919
9.81%
2658
N/A
Pharmaceuticals
Healthcare
US
Indianapolis
